NUTM2D
gene geneOn this page
Summary
NUTM2D (NUT family member 2D, HGNC:23447) is a protein-coding gene on chromosome 10q23.2, encoding NUT family member 2D (Q5VT03).
At a glance
- Clinical variants (ClinVar): 6 total
- Cancer driver (intOGen): activating (oncogene-like) across 1 cancer types
- MANE Select transcript:
NM_001382304
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23447 |
| Approved symbol | NUTM2D |
| Name | NUT family member 2D |
| Location | 10q23.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000214562 |
| Ensembl biotype | protein_coding |
| Entrez | 728130 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000381697, ENST00000412718, ENST00000465545
RefSeq mRNA: 2 — MANE Select: NM_001382304
NM_001009610, NM_001382304
CCDS: CCDS91292
Canonical transcript exons
ENST00000381697 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001489535 | 87366139 | 87367195 |
| ENSE00002430792 | 87364239 | 87364378 |
| ENSE00002431928 | 87365689 | 87365805 |
| ENSE00002463267 | 87360481 | 87361180 |
| ENSE00002502210 | 87364821 | 87365203 |
| ENSE00002515316 | 87363138 | 87363266 |
| ENSE00002709224 | 87357744 | 87358431 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 82.40.
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cortical plate | UBERON:0005343 | 82.40 | gold quality |
| apex of heart | UBERON:0002098 | 80.65 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.34 | gold quality |
| sural nerve | UBERON:0015488 | 77.31 | gold quality |
| granulocyte | CL:0000094 | 75.86 | gold quality |
| ganglionic eminence | UBERON:0004023 | 75.09 | gold quality |
| ventricular zone | UBERON:0003053 | 74.97 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 74.42 | gold quality |
| right atrium auricular region | UBERON:0006631 | 73.90 | gold quality |
| heart left ventricle | UBERON:0002084 | 73.64 | gold quality |
| amygdala | UBERON:0001876 | 73.62 | gold quality |
| temporal lobe | UBERON:0001871 | 73.56 | gold quality |
| Ammon’s horn | UBERON:0001954 | 73.56 | gold quality |
| prefrontal cortex | UBERON:0000451 | 73.52 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 73.30 | gold quality |
| substantia nigra | UBERON:0002038 | 72.99 | gold quality |
| frontal cortex | UBERON:0001870 | 72.73 | gold quality |
| heart | UBERON:0000948 | 72.70 | gold quality |
| colonic epithelium | UBERON:0000397 | 72.63 | gold quality |
| primary visual cortex | UBERON:0002436 | 72.37 | gold quality |
| fundus of stomach | UBERON:0001160 | 72.00 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 71.92 | gold quality |
| cerebral cortex | UBERON:0000956 | 71.84 | gold quality |
| right frontal lobe | UBERON:0002810 | 71.83 | gold quality |
| putamen | UBERON:0001874 | 71.82 | gold quality |
| gastrocnemius | UBERON:0001388 | 71.71 | gold quality |
| muscle tissue | UBERON:0002385 | 71.63 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 71.52 | gold quality |
| mucosa of stomach | UBERON:0001199 | 71.49 | gold quality |
| muscle of leg | UBERON:0001383 | 71.49 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.09 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Nutm2 | ENSMUSG00000071909 |
| rattus_norvegicus | Nutm2 | ENSRNOG00000027311 |
Paralogs (6): NUTM2F (ENSG00000130950), NUTM1 (ENSG00000184507), NUTM2A (ENSG00000184923), NUTM2G (ENSG00000188152), NUTM2B (ENSG00000188199), NUTM2E (ENSG00000228570)
Protein
Protein identifiers
NUT family member 2D — Q5VT03 (reviewed: Q5VT03)
All UniProt accessions (3): Q5VT03, A0A075B6P9, U3KPT3
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the NUT family.
RefSeq proteins (2): NP_001009610, NP_001369233* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR024309 | NUT_N | Domain |
| IPR024310 | NUT | Family |
Pfam: PF12881
UniProt features (9 total): region of interest 4, compositionally biased region 4, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5VT03-F1 | 48.45 | 0.05 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 3 (showing top):
chr10q23, BLANCO_MELO_MERS_COV_INFECTION_MCR5_CELLS_UP, PULVER_FOREY_CELLCYCLE_PEAKING_G2_M
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
382 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| NUTM2D | FAM25A | B3EWG3 | 528 |
| NUTM2D | Q8WV35 | Q8WV35 | 480 |
| NUTM2D | B3GNT9 | Q6UX72 | 479 |
| NUTM2D | TOGARAM2 | Q6ZUX3 | 448 |
| NUTM2D | FNDC4 | Q9H6D8 | 397 |
| NUTM2D | CES4A | Q5XG92 | 389 |
| NUTM2D | PSD2 | Q9BQI7 | 370 |
| NUTM2D | SLC9A5 | Q14940 | 355 |
| NUTM2D | RBKS | Q9H477 | 352 |
| NUTM2D | MMRN2 | Q9H8L6 | 348 |
| NUTM2D | YPEL5 | P62699 | 348 |
| NUTM2D | CAPN14 | A8MX76 | 335 |
| NUTM2D | ANKRD22 | Q5VYY1 | 324 |
| NUTM2D | NDUFC1 | O43677 | 324 |
| NUTM2D | GPAT2 | Q6NUI2 | 323 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A096LP49, A0A8V8TNH8, A0A8V8TPE2, A1L443, A2IDD5, A5D7L8, A6NDY2, A6NIJ5, A6NNJ1, A6NNL0, A7E346, A8K0R7, A8MXJ8, A8MXZ1, B1AL46, B1ASB6, C9JSJ3, E9PGG2, O08574, P0C7V4, P0C7W8, P0C7X0, P0CG20, P0DV73, P0DV75, P0DV76, Q0VG99, Q0ZCJ7, Q149B8, Q2M3G4, Q3TQ03, Q3V0C3, Q4KLY2, Q5JXC2, Q5RCJ6, Q5SV97, Q5SW24, Q5VT03, Q5VZR2, Q6ZMY3
Diamond homologs: A1L443, A6NNL0, B1AL46, Q3V0C3, Q5VT03, Q5VZR2, Q86Y26, Q8BHP2, Q8IVF1
SIGNOR signaling
0 interactions.
Disease & clinical
Cancer significance
From intOGen — cancer-driver classification: activating (oncogene-like) across 1 cancer types — NPC.
Clinical variants and AI predictions
ClinVar
6 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1187 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 10:87363136:A:AG | acceptor_gain | 1.0000 |
| 10:87363137:G:GT | acceptor_gain | 1.0000 |
| 10:87363137:GC:G | acceptor_gain | 1.0000 |
| 10:87363137:GCC:G | acceptor_gain | 1.0000 |
| 10:87363137:GCCC:G | acceptor_gain | 1.0000 |
| 10:87363137:GCCCA:G | acceptor_gain | 1.0000 |
| 10:87363262:GAAAA:G | donor_gain | 1.0000 |
| 10:87363263:AAAA:A | donor_gain | 1.0000 |
| 10:87363264:AAA:A | donor_gain | 1.0000 |
| 10:87363265:AA:A | donor_gain | 1.0000 |
| 10:87363266:AG:A | donor_loss | 1.0000 |
| 10:87363267:G:C | donor_loss | 1.0000 |
| 10:87363267:G:GG | donor_gain | 1.0000 |
| 10:87364235:CCAG:C | acceptor_loss | 1.0000 |
| 10:87364236:CAG:C | acceptor_loss | 1.0000 |
| 10:87364237:AGG:A | acceptor_loss | 1.0000 |
| 10:87364820:GT:G | acceptor_gain | 1.0000 |
| 10:87365680:T:TA | acceptor_gain | 1.0000 |
| 10:87365685:CCA:C | acceptor_loss | 1.0000 |
| 10:87365686:CA:C | acceptor_loss | 1.0000 |
| 10:87365687:A:AG | acceptor_gain | 1.0000 |
| 10:87365687:A:T | acceptor_loss | 1.0000 |
| 10:87365687:AG:A | acceptor_gain | 1.0000 |
| 10:87365687:AGGT:A | acceptor_gain | 1.0000 |
| 10:87365687:AGGTG:A | acceptor_gain | 1.0000 |
| 10:87365688:G:GA | acceptor_gain | 1.0000 |
| 10:87365688:GG:G | acceptor_gain | 1.0000 |
| 10:87365688:GGT:G | acceptor_gain | 1.0000 |
| 10:87365688:GGTG:G | acceptor_gain | 1.0000 |
| 10:87365688:GGTGG:G | acceptor_gain | 1.0000 |
AlphaMissense
5147 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 10:87361173:T:C | F287L | 0.989 |
| 10:87361175:C:A | F287L | 0.989 |
| 10:87361175:C:G | F287L | 0.989 |
| 10:87363216:G:C | W315C | 0.989 |
| 10:87363216:G:T | W315C | 0.989 |
| 10:87363214:T:A | W315R | 0.985 |
| 10:87363214:T:C | W315R | 0.985 |
| 10:87363247:T:C | F326L | 0.985 |
| 10:87363249:C:A | F326L | 0.985 |
| 10:87363249:C:G | F326L | 0.985 |
| 10:87364240:T:C | F333L | 0.984 |
| 10:87364242:C:A | F333L | 0.984 |
| 10:87364242:C:G | F333L | 0.984 |
| 10:87364249:T:C | F336L | 0.979 |
| 10:87364251:T:A | F336L | 0.979 |
| 10:87364251:T:G | F336L | 0.979 |
| 10:87363239:G:C | R323P | 0.971 |
| 10:87365713:T:C | F515L | 0.967 |
| 10:87365715:C:A | F515L | 0.967 |
| 10:87365715:C:G | F515L | 0.967 |
| 10:87363215:G:C | W315S | 0.966 |
| 10:87363232:T:C | F321L | 0.966 |
| 10:87363234:T:A | F321L | 0.966 |
| 10:87363234:T:G | F321L | 0.966 |
| 10:87364241:T:C | F333S | 0.966 |
| 10:87361104:T:A | W264R | 0.965 |
| 10:87361104:T:C | W264R | 0.965 |
| 10:87361170:T:C | C286R | 0.962 |
| 10:87361095:T:C | F261L | 0.961 |
| 10:87361097:C:A | F261L | 0.961 |
dbSNP variants (sampled 300 via entrez): RS1000000514 (10:87369855 C>A,T), RS1001600261 (10:87371019 A>G), RS1003683185 (10:87358579 G>C), RS1004243188 (10:87361200 T>TG), RS1005831300 (10:87357036 G>C), RS1006168657 (10:87367585 C>G), RS1006240743 (10:87368044 C>G,T), RS1007840837 (10:87369914 A>G), RS1008623380 (10:87355960 G>A), RS1009158699 (10:87356672 T>C,G), RS1010240098 (10:87371044 C>A,T), RS1010657929 (10:87355786 G>A), RS1012334154 (10:87365711 A>C), RS1012386665 (10:87362597 T>TA), RS1012718770 (10:87369605 C>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
11 total (human), top 11 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| ferrous chloride | decreases expression | 1 |
| perfluoro-n-nonanoic acid | increases expression | 1 |
| perfluorohexanesulfonic acid | increases expression | 1 |
| jinfukang | affects cotreatment, decreases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Cisplatin | affects cotreatment, decreases expression | 1 |
| Plant Extracts | decreases expression, affects cotreatment | 1 |
| Silicon Dioxide | increases expression | 1 |
| Urethane | increases expression | 1 |
| Acrylamide | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.